Molecular genetic analysis of the von hippel-lindau and human peroxisome proliferator-activated receptor γ tumor-suppressor genes in adenocarcinomas of the gastroesophageal junction

International Journal of Cancer

Volumn 94, Issue 6, 2001, Pages 891-895

  Wijnhoven, Bas P L ^a   Lindstedt, Eric Wim ^b   Abbou, Mustaffa ^b   Ijzendoorn, Ynske ^b   de Krijger, Ronald R ^b   Tilanus, Hugo W ^a   Dinjens, Winand N M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Adenocarcinoma; Gastroesophageal junction; Loss of heterozygosity; Mutation; Peroxisome proliferator activated receptor ; Von Hippel Lindau gene

Indexed keywords

GENE PRODUCT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ADENOCARCINOMA; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; ESOPHAGUS CARCINOMA; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LIGASES; LOSS OF HETEROZYGOSITY; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0035892366     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1559     Document Type: Article

References (34)

1. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus
2. Allelotype analysis of oesophageal adenocarcinoma: Loss of heterozygosity occurs at multiple sites
3. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms
4. Allelotype analysis of adenocarcinoma of the gastric cardia
5. Allelotype of gastric adenocarcinoma
6. Comparative genomic hybridization of cancer of the gastroesophageal junction: Deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas
7. Allelotype study of esophageal carcinoma
8. Allelotype analysis of esophageal adenocarcinomas: Evidence for the involvement of sequences on the long arm of chromosome 4
9. Suppression of tumorigenicity in three different cell lines of human oral squamous cell carcinoma by introduction of chromosome 3p via microcell-mediated chromosome transfer
10. Mutations of the VHL tumour suppressor gene in renal carcinoma
11. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas
12. Extensive mutation scanning of RET in sporadic medullar thyroid carcinoma and RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in a minority of cases
13. Loss of heterozygosity at 3p23 is correlated with poor survival in patients with colorectal carcinoma
14. Comparison of losses of heterozygosity and replication errors in primary colorectal carcinomas and corresponding liver metastases
15. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma
16. Medical significance of peroxisome proliferator-activated receptors
17. Loss-of-function mutations in PPAR gamma associated with human colon cancer
18. Establishment of cell lines from adenocarcinomas of the esophagus and gastric cardia growing in vivo and in vitro
19. E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus
20. Germline mutations in the vh1 gene in patients presenting with phaeochromocytomas
21. Von Hippel-Lindau disease
22. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions
23. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumorigenesis
24. Localization of the human betacatenin gene (CTNNB1) to 3p21: A region implicated in tumor development
25. The gene for the APC-binding protein beta-catenin (CTNNB1) maps to chromosome 3p22, a region frequently altered in human malignancies
26. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: Correlation with disease progression and dedifferentiation
27. E-cadherin-catenin cell-cell adhesion complex and human cancer
28. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas
29. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas
30. Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated esophageal adenocarcinoma
31. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation
32. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
33. Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues
34. Expression of von Hippel-Lindau protein in normal and pathological human tissues